Zhanget al. (2021) in their case report stated that there was a significant downward trend in IL-6 and IL-10 after infusion of hUCMSC at a dose of 6.4×107 twice in critically ill COVID-19 patients.24 This supports the results of our study. This evidence concerns the gene IL10 and COVID-19.